Mechanism of hypotensive action of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST-155) in the cat.
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects*; D001919:Bradycardia / Q000139:chemically induced; D001949:Bretylium Compounds / Q000494:pharmacology; D002319:Cardiovascular System / Q000187:drug effects; D002415:Cats; D003655:Decerebrate State; D004336:Drug Antagonism; D004357:Drug Synergism; D005260:Female; D006339:Heart Rate / Q000187:drug effects*; D006584:Hexamethonium Compounds; D007093:Imidazoles / Q000494:pharmacology*; D013233:Stellate Ganglion / Q000502:physiology; D013564:Sympathetic Nervous System / Q000187:drug effects; D013997:Time Factors; D014043:Tolazoline / Q000494:pharmacology
D000959:Antihypertensive Agents; D001949:Bretylium Compounds; D006584:Hexamethonium Compounds; D007093:Imidazoles; D014043:Tolazoline